{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:28:35Z","timestamp":1780104515922,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neurol.2013.07.023","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T08:30:45Z","timestamp":1378456245000},"page":"715-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies"],"prefix":"10.1016","volume":"169","author":[{"given":"G.","family":"Doroth\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aucouturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2013.07.023_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2012.08.001","article-title":"Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament","volume":"252","author":"Bartos","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0010","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.1073\/pnas.0904866106","article-title":"Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease","volume":"106","author":"Britschgi","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.neurol.2013.07.023_bib0015","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awr130","article-title":"Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease","volume":"134","author":"de Souza","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2013.07.023_bib0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archneurol.2012.604","article-title":"Distinct patterns of antiamyloid-beta antibodies in typical and atypical Alzheimer disease","volume":"69","author":"Dorothee","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.57.5.801","article-title":"Reduced levels of amyloid beta-peptide antibody in Alzheimer disease","volume":"57","author":"Du","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2013.07.023_bib0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","article-title":"Clinical manifestations of cerebral amyloid angiopathy-related inflammation","volume":"55","author":"Eng","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ana.1061","article-title":"Autoantibodies to amyloid-beta and Alzheimer's disease","volume":"49","author":"Hyman","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0045","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2013.07.023_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.21475","article-title":"Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden","volume":"65","author":"Kellner","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","article-title":"Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis","volume":"20","author":"Lambert","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2013.07.023_bib0060","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.neurobiolaging.2012.01.004","article-title":"Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia","volume":"33","author":"Lanuti","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2013.07.023_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2013.07.023_bib0070","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archneurol.2011.2441","article-title":"CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid beta-related angiitis","volume":"69","author":"Melzer","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0075","doi-asserted-by":"crossref","first-page":"17458","DOI":"10.1074\/jbc.M414176200","article-title":"Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients","volume":"280","author":"Moir","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2013.07.023_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease","volume":"112","author":"Monsonego","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2013.07.023_bib0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.11.001","article-title":"Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides","volume":"25","author":"Mruthinti","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2013.07.023_bib0090","doi-asserted-by":"crossref","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"Nagele","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2013.07.023_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/NMM:3:1:29","article-title":"Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development","volume":"3","author":"Nath","year":"2003","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neurol.2013.07.023_bib0100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","article-title":"Cerebral hemorrhage after passive anti-Abeta immunotherapy","volume":"298","author":"Pfeifer","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurol.2013.07.023_bib0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies","volume":"73","author":"Piazza","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.2923","article-title":"Heterogeneity of CNS myeloid cells and their roles in neurodegeneration","volume":"14","author":"Prinz","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2013.07.023_bib0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2010.11.054","article-title":"Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening","volume":"144","author":"Reddy","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2013.07.023_bib0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.22405","article-title":"Application of immunosignatures to the assessment of Alzheimer's disease","volume":"70","author":"Restrepo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0125","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0b013e31821cccad","article-title":"Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution","volume":"76","author":"Rosenbloom","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2013.07.023_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","article-title":"Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration","volume":"188","author":"Rosenkranz","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2013.07.023_bib0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-2010-091696","article-title":"PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease","volume":"21","author":"Saresella","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2013.07.023_bib0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/brain\/awh379","article-title":"Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy","volume":"128","author":"Scolding","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2013.07.023_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0155","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archneurol.2010.137","article-title":"Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment","volume":"67","author":"Storace","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0160","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1003953","article-title":"MHC-independent genetic factors control the magnitude of CD4+ T cell responses to amyloid-beta peptide in mice through regulatory T cell-mediated inhibition","volume":"187","author":"Toly-Ndour","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0531-5565(02)00029-3","article-title":"Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals","volume":"37","author":"Weksler","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurol.2013.07.023_bib0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/187152709787601858","article-title":"Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice","volume":"8","author":"Wilcock","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:46:41Z","timestamp":1563875201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378713008825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0035378713008825"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2013.07.023","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2013.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}